Valuation: AstraZeneca PLC

Market Cap 301B 263B 242B 226B 428B 28,691B 434B 2,906B 1,130B 14,103B 1,131B 1,107B 48,599B P/E 2026 *
24.2x
P/E 2027 * 21.3x
Enterprise Value 321B 280B 258B 240B 455B 30,526B 462B 3,092B 1,202B 15,005B 1,203B 1,178B 51,706B EV / Sales 2026 *
5.06x
EV / Sales 2027 * 4.68x
Free-Float
96.63%
Yield 2026 *
1.72%
Yield 2027 * 1.81%
1 day-0.45%
1 week+2.80%
Current month+2.52%
1 month+9.40%
3 months-5.62%
6 months+6.36%
Current year+4.83%
1 week 13,838
Extreme 13838
14,686
1 month 11,364
Extreme 11364
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,122
Extreme 10122
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%+2.80%+39.13%+28.20% 301B
+1.86%+7.65%+55.77%+158.84% 1,082B
+3.57%+7.42%+69.09%+58.92% 633B
+3.99%+7.37%+36.87%+93.77% 461B
-0.35%+1.85%+31.30%+24.86% 339B
-0.08%+1.52%+29.96%+42.13% 292B
-1.54%+3.56%-25.96%-40.53% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+4.21%+6.00%+17.72%+70.33% 163B
+1.84%+2.75%-3.95%-33.70% 139B
Average +1.16%+4.36%+27.60%+47.13% 383.83B
Weighted average by Cap. +1.07%+5.32%+40.13%+76.40%

Financials

2026 *2027 *
Net sales 63.33B 55.36B 50.88B 47.43B 89.95B 6,030B 91.32B 611B 237B 2,964B 238B 233B 10,214B 67.02B 58.59B 53.84B 50.19B 95.2B 6,381B 96.64B 646B 251B 3,137B 252B 246B 10,809B
Net income 12.47B 10.9B 10.02B 9.34B 17.71B 1,187B 17.98B 120B 46.76B 584B 46.81B 45.8B 2,011B 14.01B 12.24B 11.25B 10.49B 19.89B 1,334B 20.2B 135B 52.51B 656B 52.57B 51.44B 2,259B
Net Debt 19.27B 16.84B 15.48B 14.43B 27.37B 1,834B 27.78B 186B 72.24B 902B 72.32B 70.77B 3,107B 12.02B 10.51B 9.66B 9B 17.08B 1,145B 17.34B 116B 45.08B 563B 45.13B 44.16B 1,939B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-03 GBX 14,456.00 -0.56% 576,018
26-07-02 GBX 14,538.00 +4.94% 2,810,574
26-07-01 GBX 13,854.00 -1.74% 1,804,499
26-06-30 GBX 14,100.00 -1.38% 2,513,351
26-06-29 GBX 14,298.00 -0.14% 1,883,887
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
194.29USD
Average target price
217.82USD
Spread / Average Target
+12.11%

Quarterly revenue - Rate of surprise